239 related articles for article (PubMed ID: 17704408)
21. Upfront treatment of locally advanced cervical cancer with intensity modulated radiation therapy compared to four-field radiation therapy: a cost-effectiveness analysis.
Lesnock JL; Farris C; Beriwal S; Krivak TC
Gynecol Oncol; 2013 Jun; 129(3):574-9. PubMed ID: 23500086
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer.
Zemplényi AT; Kaló Z; Kovács G; Farkas R; Beöthe T; Bányai D; Sebestyén Z; Endrei D; Boncz I; Mangel L
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 26782759
[TBL] [Abstract][Full Text] [Related]
23. Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy.
Schroeck FR; Jacobs BL; Bhayani SB; Nguyen PL; Penson D; Hu J
Eur Urol; 2017 Nov; 72(5):712-735. PubMed ID: 28366513
[TBL] [Abstract][Full Text] [Related]
24. Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care.
Kamran SC; Light JO; Efstathiou JA
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):509-521. PubMed ID: 30967625
[TBL] [Abstract][Full Text] [Related]
25. A model of the cost-effectiveness of intensity-modulated radiotherapy in comparison with three-dimensional conformal radiotherapy for the treatment of localised prostate cancer.
Hummel SR; Stevenson MD; Simpson EL; Staffurth J
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e159-67. PubMed ID: 23040143
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of SBRT versus IMRT: an emerging initial radiation treatment option for organ-confined prostate cancer.
Hodges JC; Lotan Y; Boike TP; Benton R; Barrier A; Timmerman RD
Am J Manag Care; 2012 May; 18(5):e186-93. PubMed ID: 22694113
[TBL] [Abstract][Full Text] [Related]
27. A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed.
Carter HE; Martin A; Schofield D; Duchesne G; Haworth A; Hornby C; Sidhom M; Jackson M
Radiother Oncol; 2014 Aug; 112(2):187-93. PubMed ID: 24929702
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of proton beam therapy for intraocular melanoma.
Moriarty JP; Borah BJ; Foote RL; Pulido JS; Shah ND
PLoS One; 2015; 10(5):e0127814. PubMed ID: 25993284
[TBL] [Abstract][Full Text] [Related]
29. Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children.
Mailhot Vega R; Kim J; Hollander A; Hattangadi-Gluth J; Michalski J; Tarbell NJ; Yock TI; Bussiere M; MacDonald SM
Cancer; 2015 May; 121(10):1694-702. PubMed ID: 25641407
[TBL] [Abstract][Full Text] [Related]
30. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer.
Vu CC; Blas KG; Lanni TB; Gustafson GS; Krauss DJ
Brachytherapy; 2018; 17(6):852-857. PubMed ID: 30076108
[TBL] [Abstract][Full Text] [Related]
32. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
[TBL] [Abstract][Full Text] [Related]
33. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
[TBL] [Abstract][Full Text] [Related]
34. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
[TBL] [Abstract][Full Text] [Related]
35. Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
Li G; Xia YF; Huang YX; Okat D; Qiu B; Doyen J; Bondiau PY; Benezery K; Gao J; Qian CN
BMC Cancer; 2021 Aug; 21(1):944. PubMed ID: 34419008
[TBL] [Abstract][Full Text] [Related]
36. Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning.
Hug EB; Fitzek MM; Liebsch NJ; Munzenrider JE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):467-76. PubMed ID: 7852108
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness studies in radiation therapy.
Sher DJ
Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):567-82. PubMed ID: 20950072
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma.
Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
Cancer; 2005 Feb; 103(4):793-801. PubMed ID: 15637691
[TBL] [Abstract][Full Text] [Related]
39. Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer.
Shah C; Lanni TB; Ghilezan MI; Gustafson GS; Marvin KS; Ye H; Vicini FA; Martinez AA
Brachytherapy; 2012; 11(6):441-5. PubMed ID: 22728157
[TBL] [Abstract][Full Text] [Related]
40. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.
Zeliadt SB; Etzioni RD; Penson DF; Thompson IM; Ramsey SD
Am J Med; 2005 Aug; 118(8):850-7. PubMed ID: 16084177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
